A major cause of hospital-acquired infections, the super bacteria Methicillin-resistant Staphylococcus aureus (MRSA), not ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to deliver genetic therapies straight to lung cells. This innovation could transform ...

Researchers have developed a lung-targeted nanoparticle delivery system for genetic therapies. In a major step forward for ...

SpliceBio's lead in-house pipeline project is in Stargardt disease, an IRD with no approved therapies that is caused by ...

Sarepta’s shares crashed 41% in premarket trading Monday morning to $21.01 after the biotech reported a second death from ...

Global Fulcrum™ license spans 20 countries for trait development in maize, wheat, sorghum, millets, pigeon pea, and groundnutDurham, N.C., and Texcoco, Mexico, June 12, 2025 (GLOBE NEWSWIRE) -- ...

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

The company’s intein-based technology is initially aimed at Stargardt disease, a type of macular degeneration.

Editas Medicine ( EDIT 12.04%) is a promising clinical-stage company that has captured Wall Street's attention at the ...

Eli Lilly acquires Verve Therapeutics, Inc. for $1B to advance gene-editing therapies like VERVE-102, targeting ASCVD. Click ...